Skip to content
October 11, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Global Breast Cancer Awareness
  • A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan
  • Global Breast Cancer Awareness

A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan

Rifan Muazin October 10, 2026 7 minutes read
a-beacon-of-resilience-who-director-general-strengthens-global-health-ties-during-landmark-visit-to-jordan

AMMAN — The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded the first leg of a pivotal two-day State visit to the Hashemite Kingdom of Jordan. The visit serves as a high-level endorsement of Jordan’s burgeoning role as a regional anchor for medical stability, humanitarian intervention, and innovative healthcare policy.

Against a backdrop of regional volatility, the visit underscored the deepening partnership between the WHO and the Jordanian government, with a specific focus on universal health coverage (UHC), the integration of mental health services into primary care, and the sustained management of humanitarian health emergencies.


The Core Objectives: A Vision for Regional Health Security

The primary objective of Dr. Tedros’ visit was to synchronize global health strategies with Jordan’s national health priorities. As the Kingdom continues to host over three million refugees—primarily from Syria and Gaza—its healthcare system has become a vital lifeline. The discussions held in Amman centered on three strategic pillars:

  1. Systemic Resilience: Strengthening Jordan’s primary healthcare infrastructure to ensure it can withstand the dual pressures of local demand and regional refugee surges.
  2. Humanitarian Diplomacy: Validating the “Medical Corridor” initiative, a unique diplomatic and logistical feat that allows critically ill and injured Gazan civilians, particularly children, to access specialized treatment within Jordanian facilities.
  3. Mental Health Advocacy: Scaling up mental health support for conflict-affected populations, shifting the paradigm from emergency crisis response to long-term community recovery.

Chronology of the Visit: A Day of High-Level Engagement

The first day of the visit was defined by a series of high-stakes diplomatic and field-based engagements, reflecting the multi-faceted nature of the WHO’s mission.

Morning: A Royal Audience

The day commenced with a meeting with His Majesty King Abdullah II. This session highlighted Jordan’s unique position as a regional leader in healthcare. Discussions focused on the intersection of national policy and global responsibility, with King Abdullah II reaffirming his commitment to maintaining Jordan’s health sector as a beacon of stability for the region. Dr. Tedros praised the King’s vision, noting that the Jordanian approach provides a global blueprint for how middle-income countries can integrate humanitarian needs into their national development agendas.

Midday: The Human Cost of Conflict

Dr. Tedros conducted a sobering site visit to a WHO-supported hospital currently treating children evacuated from Gaza. The visit was not merely administrative; it involved direct engagement with young patients and their families. Witnessing the frontline delivery of care for cancer and severe trauma, the Director-General emphasized the urgency of keeping the medical evacuation corridors open. He described these efforts as the "moral imperative" of the international community, urging donor countries to ensure that financial support for these initiatives remains consistent.

Afternoon: Mobilizing Global Partners

In a high-level roundtable with UN agencies, donor countries, and philanthropic organizations, Dr. Tedros shifted the focus to financing. He addressed the "donor fatigue" that often affects long-term refugee hosting nations. By bringing together major stakeholders, the WHO aimed to secure commitments for sustainable funding cycles rather than sporadic emergency grants, ensuring that mental health services and primary care centers in Jordan remain operational through 2025 and beyond.


Supporting Data and Strategic Partnerships

Jordan’s healthcare system is currently navigating one of the most challenging demographic landscapes in the world. The Kingdom manages a population that has been significantly expanded by refugee arrivals, placing immense strain on local clinics and national hospitals.

The Archewell Philanthropies Collaboration

A notable feature of this visit was the participation of the Duke and Duchess of Sussex, Prince Harry and Meghan. As founders of Archewell Philanthropies, the couple has been long-standing partners of the WHO. Their involvement in the Jordan visit served to amplify the visibility of the mental health crisis currently unfolding in conflict zones.

Prince Harry, speaking on the necessity of addressing psychological trauma, noted, "Mental health is fundamental to recovery, dignity, and long-term peace." The collaboration with Archewell is focused on reducing the stigma surrounding mental health—a significant hurdle in many Middle Eastern communities—and training local community health workers to identify and treat PTSD in children and men, two groups often overlooked in emergency settings.

Mental Health as a Pillar of UHC

Jordan has made significant strides in the WHO’s "Special Initiative for Mental Health," which aims to integrate psychological services into standard primary care. By training general practitioners to handle basic mental health screenings and interventions, Jordan is successfully decentralizing care, making it more accessible and less stigmatized than traditional psychiatric institutions.


Official Responses and Diplomatic Statements

The discourse surrounding the visit was characterized by mutual respect and a shared sense of urgency.

Dr. Tedros Adhanom Ghebreyesus:

"I extend my thanks to His Majesty and the people of Jordan for their solidarity and generosity. Jordan continues to show the world what it truly means to put health and humanity first. We are grateful for the Medical Corridor initiative, which serves as a vital artery for the most vulnerable."

Prince Harry, Duke of Sussex:

"It is an honour to join the Director-General in Jordan, a country that is leading by example in compassion, resilience, and innovation. Through our work with Archewell, we have seen first-hand the impact of WHO’s efforts. We remain committed to expanding access to mental health support for all those affected by conflict."


Implications: The Road Ahead

The implications of this visit extend far beyond the borders of Jordan. The WHO’s endorsement of Jordan’s healthcare model signals a shift in how the global body views "hosting nations." Rather than treating them merely as temporary shelters, the WHO is treating countries like Jordan as strategic hubs for regional medical resilience.

Future Initiatives

As the visit moves into its second day, the agenda remains packed with critical site visits and policy discussions. Key upcoming engagements include:

  • The National Center for Rehabilitation of Addicts: Dr. Tedros is scheduled to evaluate the center’s integrated medical and psychological service model, which the WHO hopes to replicate in other post-conflict nations.
  • The King Hussein Cancer Center: This visit will focus on regional collaboration in specialized oncology, exploring how Jordan can become a central hub for cancer treatment for patients from neighboring countries who have lost access to local facilities.
  • Community Engagement: Meetings with the Jordanian Hashemite Fund for Human Development will highlight the role of women and grassroots organizations in maintaining health equity.

The Call for Sustained Investment

The primary takeaway from the first day is a clear, unequivocal call to action for the international donor community. While Jordan’s humanitarian spirit is unwavering, the physical and financial resources required to maintain this level of care are finite. The WHO’s visit is, in effect, a lobby for the "Jordanian Model"—a call for international donors to invest in the host country’s infrastructure rather than just the immediate needs of refugees.

By strengthening the Jordanian health system, the WHO argues that the region becomes more stable, more equitable, and better prepared for future crises. The visit concludes tomorrow, but the momentum generated in Amman is expected to influence WHO humanitarian strategy for the remainder of the fiscal year.


Reported by:
Paul Garwood, Communications Officer, WHO
The WHO Media Team, World Health Organization

About the Author

Rifan Muazin

Administrator

View All Posts

Post navigation

Previous: Navigating Life Beyond Treatment: A Comprehensive Guide to Breast Cancer Canada’s Fall Webinar Series
Next: A Global Beacon of Hope: #LightUpMBC Shines a Necessary Spotlight on Metastatic Breast Cancer

Related Stories

a-fractured-partnership-the-world-health-organization-reflects-on-the-u-s-withdrawal-and-the-lessons-of-the-pandemic
  • Global Breast Cancer Awareness

A Fractured Partnership: The World Health Organization Reflects on the U.S. Withdrawal and the Lessons of the Pandemic

Nana Muazin October 10, 2026
bridging-the-divide-new-national-survey-reveals-urgent-call-for-standardized-breast-cancer-care-across-canada-4
  • Global Breast Cancer Awareness

Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada

Ammar Sabilarrohman October 10, 2026
a-beacon-of-resilience-who-director-general-strengthens-global-health-ties-during-landmark-visit-to-jordan-1
  • Global Breast Cancer Awareness

A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan

Azzam Bilal Chamdy October 10, 2026

Recent Posts

  • Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth
  • Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research
  • Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research
  • FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-cancers-master-manipulator-ou-research-reveals-how-aggressive-breast-tumors-hijack-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026
alumis-poised-to-enter-crowded-psoriasis-market-with-promising-tyk2-inhibitor-envudeucitinib
  • Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.